Tnk1/Kos1 knockout mice develop spontaneous tumors

Sarasija Hoare1, Kishalay Hoare, Mary K Reinhard

  • 1Department of Medicine, University of Florida Shands Cancer Center, Gainesville, Florida 32610-3633, USA.

Cancer Research
|November 1, 2008
PubMed

Insights

Tnk1/Kos1, a protein tyrosine kinase, acts as a tumor suppressor by inhibiting cell growth. Its absence leads to increased Ras activity and a higher incidence of spontaneous tumors in mice.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Tnk1/Kos1 is a non-receptor protein tyrosine kinase.
  • Its catalytic activity is crucial for negatively regulating cell growth.
  • Dysregulation of Tnk1/Kos1 is linked to cancer development.

Purpose of the Study:

  • To investigate the role of Tnk1/Kos1 in tumor suppression.
  • To elucidate the mechanism by which Tnk1/Kos1 regulates cell growth and Ras activation.

Main Methods:

  • Generation of Tnk1/Kos1 null mice using homologous recombination.
  • Analysis of tumor development rates in Tnk1 heterozygous and null mice.
  • Assessment of Ras activation levels and Ras-guanine exchange factor (GEF) activity in Tnk1-deficient cells.
  • Investigation of Tnk1/Kos1's direct interaction with Grb2.

Main Results:

  • Tnk1/Kos1 null mice exhibit high rates of spontaneous lymphomas and carcinomas.
  • Tnk1/Kos1 expression is silenced in tumors, associated with promoter hypermethylation.
  • Tnk1/Kos1 deficiency leads to increased basal and EGF-stimulated Ras activation due to elevated Ras-GEF activity.
  • Tnk1/Kos1 directly phosphorylates Grb2, disrupting the Grb2-Sos1 complex and suppressing Ras activation.

Conclusions:

  • Tnk1/Kos1 functions as a tumor suppressor by down-regulating Ras activity.
  • The catalytic activity of Tnk1/Kos1 is essential for its tumor-suppressive function.
  • Tnk1/Kos1's mechanism involves regulating Ras-guanine exchange factor activity through Grb2 phosphorylation.